Modified staging system for extremity soft tissue sarcomas

Annals of Surgical Oncology

Volumn 6, Issue 1, 1999, Pages 57-69

  Ramanathan, Ramesh Chandran ^a   A'Hern, Roger ^b   Fisher, Cyril ^b   Thomas, J Meirion ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Prognostic factors; Soft tissue sarcoma; Staging

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SARCOMA; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARM; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 0032985028     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0057-9     Document Type: Article

References (63)

1. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd ed. St. Louis: Mosby-Year Book, 1995:1-16.
2. Cutler SJ, Young IL. Third National Cancer Survey. Incidence data. NG Monograph 1984;41:1.
3. Coindre JM, Terrier P, Bui NB, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996;14:869-77.
4. Pisters PWT, Leung DHY, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-89.
5. El-Jabbour JN, Akhtar SS, Kerr GR, McLauren KM, Smyth JF, Rodger A, Leonard RCF. Prognostic factors for survival in soft tissue sarcomas. Br J Cancer 1990;62:857-61.
6. Mandard AM, Petiot JF, Marnay J, et al. Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 1989;63:1437-51.
7. Ravaud A, Bui NB, Coindre JM, et al. Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 1992;66: 961-9.
8. Ueda T, Aozasa K, Tsujimoto M, et al. Multivariate analysis for clinical prognostic factors in 163 patients with soft tissue sarcomas. Cancer 1988;62:1444-50.
9. Rooser B, Attewell R, Berg NO, Rydholm A. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis. Acta Orthop Scand 1987;58:516-22.
10. Heise HW, Myers MH, Russell WO, et al. Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 1986;57:172-7.
11. Markhede G, Angervall L, Stener B. A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 1982;49:1721-33.
12. Gaynor JJ, Tan CC, Casper ES, et al. Refinement of clinicopathologic staging for localized soft tissue sarcomas of the extremity. A study of 423 adults. J Clin Oncol 1992;10:1317-29.
13. Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 1994;219:165-73.
14. Alvegard TA, Berg NO, Ranstam J, Rydholm A, Rooser B. Prognostication in high grade soft tissue sarcomas of the extremities. The Scandinavian Sarcoma Group experience in randomized adjuvant chemotherapy trial. Acta Orthop Scand 1989;60:517-21.
15. Collin C, Godbold J, Hajdu S, Brennan M. Localized extremity soft tissue sarcoma. An analysis of factors affecting survival. J Clin Oncol 1987;5:601-12.
16. LeVay J, O'Sullivan B, Catton C, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993;27:1091-9.
17. Cakir S, Dincbas FO, Uzel O, Koca SS, Okkan S. Multivariate analysis of prognostic factors in 75 patients with soft tissues sarcoma. Radiother Oncol 1995;37:10-16.
18. Lack EE, Steinberg SM, White DE, Kinsella T, Glatstein E, Chang AF, Rosenberg SA. Extremity soft tissue sarcomas. Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher grade sarcomas. J Surg Oncol 1989;41:263-73 .
19. Sears HF, Hopson R, Inouye W, Rizzo T, Grotzinger PJ. Analysis of staging and management of patients with sarcoma. A ten year experience. Ann Surg 1980;191:488-93.
20. Stotter AT, A'Hern RP, Fisher C, Mott AF, Fallowfield ME, Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 1990;65:1119-29.
21. Ruka W, Emrich LJ, Driscoll DL, Karakousis CP. Clinical factors and treatment parameters affecting prognosis in adult high grade soft tissue sarcomas. A retrospective review of 267 cases. Eur J Surg Oncol 1989;15:411-23.
22. Tsujimoto M, Aozasa K, Ueda T, Morimura Y, Komatsubara Y, Doi T. Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer 1988;62:994-8.
23. Tanabe KK, Pollock RE, Ellis LM, Murphy A, Sherman N, Romsdahl MM. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 1994;73:1652-9.
24. Herbert SH, Corn BW, Solin LJ, Lanciano RM, Schultz DJ, McKenna WG, Coia LR. Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer 1993;72:1230-8.
25. Serpell JW, Ball ABS, Robinson MH, Fryatt I, Fisher C, Thomas JM. Factors influencing local recurrence and survival in patients with soft tissue sarcoma of the upper limb. Br J Surg 1991;78: 1368-72.
26. Saddegh MK, Lindholm J, Lundberg A, Nilsonne U, Kreicbergs A. Staging of soft tissue sarcomas. Prognostic analysis of clinical and pathological features. J Bone Joint Surg (Br) 1992;74:495-500.
27. Peabody TD, Monson D, Montag A, Schell MJ, Finn H, Simon MA. A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. J Bone Joint Surg (Am) 1994;76: 1167-73.
28. Tomita Y, Kuratsu S, Naka N, Uchida A, Ono K, Ohsawa M, Aozasa K. A staging system for soft tissue sarcoma and its evaluation in relation to treatment. Int J Cancer 1994;58:168-73.
29. Russell WO, Cohen J, Enzinger FM, et al. A clinical and pathological staging system for soft tissue sarcomas. Cancer 1977;40: 1562-70.
30. Hadju SI. Pathology of soft tissue tumors. Philadelphia: Lea and Febiger, 1979:43-7.
31. Enneking WF, Spanier SS, Goodman MA. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg (Am) 1980;62:1027-30.
32. Rooser BO, Attewell R, Berg NO, Rydholm A. Prognostication in soft tissue sarcoma. A model with four risk factors. Cancer 1988; 61:817-23.
33. Alvegard TA, Berg NO, Baldetorp B, et al. Cellular DNA content and prognosis of high grade soft tissue sarcoma. The Scandinavian sarcoma group experience. J Clin Oncol 1990;8:538-47.
34. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for staging of cancer, ed. 4. Philadelphia: JB Lippincott, 1992: 131-5.
35. Hermanek P, Sobin LH. TNM classification of malignant tumors. International union against cancer, ed. 4, 2nd version. Berlin: Springer-Verlag, 1992:25-8.
36. Pitcher ME, Thomas JM. Functional compartmental resection for soft tissue sarcomas. Eur J Surg Oncol 1994;20:441-5.
37. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults. Study of pathological prognostic variables and definition of histopathological grading system. Int J Cancer 1984;33:37-42.
38. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958;53:457-81.
39. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
40. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B 1972;34:187-220.
41. Lindberg RD, Martin RG, Romsdahl MM, Barkley HT. Conservative surgery and postoperative radiotherapy in 300 adults with soft tissue sarcomas. Cancer 1981;47:2391-7.
42. Collin C, Hajdu SI, Godbold J, Shiu MH, Hilaris BI, Brennan MF. Localized operable soft tissue sarcoma of the lower extremity. Arch Surg 1986;121:1425-33.
43. Heslin MJ, Woodruff J, Brennan MF. Prognostic significance of a positive microscopic margin in high risk extremity soft tissue sarcoma. Implications for management. J Clin Oncol 1996;14: 473-8.
44. Collin CF, Friedrich C, Godbold J, Hajdu S, Brennan M. Prognostic factors for local recurrence and survival in patients with localized extremity soft tissue sarcoma. Semin Surg Oncol 1988;4: 30-7.
45. Heslin MJ, Gaynor JJ, Newman E, Wolf RF, Woodruff J, Casper ES, Brennan MF. Effect of perioperative blood transfusion on recurrence and survival in 232 primary high grade extremity sarcoma patients. Ann Surg Oncol 1994;1:189-97.
46. Suit HD, Mankin HJ, Wood WC, et al. Treatment of the patient with stage MO soft tissue sarcoma. J Clin Oncol 1988;6:854-62.
47. Lawrence W, Donegan WL, Natarajan N, Mettlin C, Beart R, Winchester D. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 1987;205:349-59.
48. Potter DA, Kinsella T, Glatstein E, et al. High grade soft tissue sarcomas of the extremities. Cancer 1986;58:190-205.
49. Suit HD. Patterns of failure after treatment of sarcoma of soft tissue by radical surgery or by conservative surgery and radiation. Cancer Treat Symp 1983;2:241-6.
50. Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg 1975; 182:597-602.
51. Abbas JS, Holyoke ED, Moore R, Karakousis CP. The surgical treatment and outcome of soft tissue sarcoma. Arch Surg 1981; 116:765-9.
52. Van Unnik JAM, Coindre JM, Contesso C, et al. Grading of soft tissue sarcomas. Experience of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 1993;29A:2089-93.
53. Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58:306-9.
54. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcoma. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984;53:530-41.
55. Myhre-Jensen O, Kaae S, Madsen EH, Sneppen O. Histopathological grading in soft tissue tumor. Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand 1983;91A:145-50.
56. Tomito Y, Aozasa K, Myoui A, Kuratsu S, Uchida A, Ono K, Matsumoto K. Histologic grading in soft tissue sarcomas. An analysis of 194 cases including AgNOR count and mast cell count. Int J Cancer 1993;54:194-9.
57. Alvegard TA, Berg NO. Histopathology peer review of high grade soft tissue sarcoma. The Scandinavian sarcoma group experience. J Clin Oncol 1989;7:1845-51.
58. Rydholm A, Gustafson P, Rooser BO, Willen H, Berg NO. Subcutaneous sarcoma. A population based study of 129 patients. J Bone Joint Surg (Br) 1991;73:662-7.
59. Rydholm A, Syk I. Malignant fibrous histiocytoma of soft tissue. Correlation between clinical variables and histologic malignancy grade. Cancer 1986;57:2323-4.
60. Donohue JH, Collin C, Friedrich C, Godbold J, Hajdu SI, Brennan MF. Low grade soft tissue sarcoma of the extremities. Analysis of risk factors for metastasis. Cancer 1988;62:184-93.
61. Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft tissue sarcoma of the extremity in adults. Arch Surg 1992;127:1285-9.
62. Rooser B, Attewell R, Rydholm A. The staging of soft tissue sarcomas. Int Orthop 1987;11:339-43.
63. Brennan MF. Management of soft tissue sarcoma. Br J Surg 1996;83:577-79.